EQUITY RESEARCH MEMO

Image Analysis Group

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)60/100

Image Analysis Group (IAG) is a London-based imaging contract research organization (CRO) specializing in centralized image management and analysis for clinical trials. Leveraging its proprietary DYNAMIKA AI platform and a network of expert radiologists, IAG provides regulatory-compliant imaging endpoints across musculoskeletal, oncology, and metabolic diseases. Founded in 2007, the company has established a niche in AI-driven imaging CRO services, enabling faster and more accurate assessment of therapeutic efficacy in clinical trials. While financial details and stage are undisclosed, IAG's focus on AI-powered, regulatory-grade imaging positions it well in the growing digital CRO market, driven by increasing trial complexity and demand for quantitative imaging biomarkers. Its private status and lack of recent funding disclosures suggest a bootstrapped or steady-state operation, but the company remains a relevant player in the specialized imaging CRO space.

Upcoming Catalysts (preview)

  • Q4 2026Expansion of DYNAMIKA platform into new therapeutic areas (e.g., neurology or cardiovascular)60% success
  • Q3 2026Securing a strategic partnership with a top-20 pharmaceutical company for multi-trial imaging services40% success
  • TBDRegulatory qualification of DYNAMIKA as a biomarker analysis platform by a major health authority30% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)